Myanmar vs Thailand: Cause of death, by non-communicable diseases, ages 60+
Myanmar
72.2%
in 2021
Thailand
72.6%
in 2021
Myanmar rank
90th
Thailand rank
88th
Cause of death, by non-communicable diseases, ages 60+ over time
- Myanmar
- Thailand
How they compare
Thailand currently reports 72.6% against 72.2% in Myanmar, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Thailand ahead.
Myanmar ranks 90th and Thailand ranks 88th of 185 countries.
Across the 3 decades both report, Myanmar averaged higher in 1 and Thailand in 2.
Head to head by decade
| Decade | Myanmar | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.2% | 77.8% | 5.6% | Thailand |
| 2010s | 82.4% | 82.5% | 0.1% | Thailand |
| 2020s | 78.1% | 77.2% | 0.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Myanmar or Thailand?
- Thailand, at 72.6% against 72.2% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Myanmar and Thailand?
- 0.4%, with Thailand ahead.
- How many years of comparable data are there for Myanmar and Thailand?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Thailand rank globally for cause of death, by non-communicable diseases, ages 60+?
- Myanmar ranks 90th and Thailand ranks 88th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.